EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

51 hedge funds and large institutions have $6.08M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$488K
2
+$21.5K
3
+$9.52K
4
TSS
Two Sigma Securities
New York
+$5.55K
5
Simplex Trading
Simplex Trading
Illinois
+$2.59K

Top Sellers

1
-$336K
2
-$147K
3
-$114K
4
Renaissance Technologies
Renaissance Technologies
New York
-$50K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$41.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6.83K
27
$6.62K
28
$6.3K
29
$6.19K
30
$5.46K
31
$5.03K
32
$4.76K
33
$4.49K
34
$4.42K
35
$3K
36
$2.56K
37
$1.86K
38
$1.14K
39
$892
40
$707
41
$383
42
$346
43
$122
44
$113
45
$103
46
$53
47
$28
48
$18
49
–
50
–
1
2
3